Shilpa Medicare gets USFDA nod for cancer treatment injection

NEW DELHI: Shilpa Medicare Tuesday said it has received approval from the US health regulator for Irinotecan HCL injection, used for treatment of certain kind of cancers.

The company has received US Food and Drug Administration (USFDA) approval for its ANDA Irinotecan HCL injection USP in the strengths 40 mg/2mL and 100 mg/5mL (20mg/mL) single dose vials, Shilpa Medicare said in a BSE filing.

Irinotecan injection is used in the treatment of patients with metastatic carcinoma of the colon or rectum, the company added.

Quoting IQVIA MAT second quarter 2018 data, Shilpa Medicare said the US market for Irinotecan HCL is approximately USD 18 million.

Shares of Shilpa Medicare were trading 3.80 per cent up at Rs 398.65 apiece on BSE.

  • Related Posts

    FSSAI prohibits Dabur from selling food products with ‘100%’ claims

    FSSAI asserted that the use of the 100% claims is in contravention of the FSS (Advertising & Claims) Regulations, 2018, as they are ambiguous, unverifiable and likely to mislead consumers…

    ORSL reinforces its commitment to improve diarrhoeal prevention in children

    Makers of ORSL, a leading oral rehydration salts (ORS) brand based on the World Health Organization (WHO) formula, in partnership with Population Services International India (PSI India), reaffirmed its commitment…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    FSSAI prohibits Dabur from selling food products with ‘100%’ claims

    FSSAI prohibits Dabur from selling food products with ‘100%’ claims

    ORSL reinforces its commitment to improve diarrhoeal prevention in children

    ORSL reinforces its commitment to improve diarrhoeal prevention in children

    ‘Donors got mixer grinders, cash’: blood banks in Bengal under scanner over ‘illegal’ sale to other States

    ‘Donors got mixer grinders, cash’: blood banks in Bengal under scanner over ‘illegal’ sale to other States

    CREATE Medicines expands targeted in vivo CAR platform through strategic research collaboration and exclusive license pact with Monash University

    CREATE Medicines expands targeted in vivo CAR platform through strategic research collaboration and exclusive license pact with Monash University

    CBN Dismantles Major Inter-State Counterfeit Drug Network In Bihar Under ‘Operation Vajra’; Mastermind Arrested

    CBN Dismantles Major Inter-State Counterfeit Drug Network In Bihar Under ‘Operation Vajra’; Mastermind Arrested

    Ministry of Ayush signs MoU with IndiaAI to harness AI for the future of traditional medicine

    Ministry of Ayush signs MoU with IndiaAI to harness AI for the future of traditional medicine